Consumers Union, the advocacy division of nonprofit Consumer Reports, writes today to express our opposition to the Right to Try Act of 2018 (H.R.5247), currently being considered by the House of Representatives. Consumers Union has a long history of working for a fairer and more just marketplace for consumers, including advocating for effective and affordable drugs for consumers. We believe the Right to Try Act would erode FDA’s current system of drug approval and oversight and, more importantly, could weaken consumer trust in the medications that are recommended and made available to them.